Hong Kong Med J 2023;29(Suppl 7):S14-7
Serum microRNA test to identify individuals with high risk of colorectal cancer: abridged secondary publication
CC Foo1, CKH Wong2,3,4, WL Law1, CLK Lam3, WK Leung5, L Ng1
1 Department of Surgery, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
2 Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
3 Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
4 Laboratory of Data Discovery for Health, Hong Kong SAR, China
5 Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
 
 
  1. A serum microRNA test is a promising diagnostic biomarker for patients with colorectal cancer.
  2. The combination of a serum microRNA test and colonoscopy is more cost-effective than colonoscopy alone.